Welcome to our dedicated page for Franklin Covey Co SEC filings (Ticker: FC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles Franklin Covey Co. (NYSE: FC) filings with the U.S. Securities and Exchange Commission, giving investors structured access to the company’s regulatory disclosures. As a Utah-incorporated issuer with Commission File No. 001-11107, Franklin Covey files current reports, proxy statements, and other documents that describe its financial condition, governance, and material events.
Recent Form 8-K filings report quarterly and annual financial results, including revenue by division and segment, subscription and subscription services revenue, deferred subscription revenue, and non-GAAP measures such as Adjusted EBITDA and Free Cash Flow. Other 8-K filings announce conference calls for earnings releases, executive leadership changes, and details of share repurchase authorizations and Rule 10b5-1 trading plans.
The company’s definitive proxy statement (DEF 14A) provides information on the annual meeting of shareholders, director elections, advisory votes on executive compensation, ratification of the independent registered public accounting firm, and broader governance topics. It also includes sections on board committees, corporate responsibility and sustainability, principal holders of voting securities, related-party transactions, and executive compensation, including pay versus performance disclosures.
Through this filings page, users can review how Franklin Covey presents its financial performance, capital allocation decisions, and governance practices in official SEC documents. Stock Titan’s platform layers AI-powered summaries and highlights on top of these filings to help readers quickly understand key points in lengthy reports, such as earnings-related 8-Ks or proxy materials, while still allowing access to the full original documents for detailed analysis.
Franklin Covey reported second quarter fiscal 2026 revenue of $59.6 million, essentially flat with last year, while posting a net loss of $2.0 million or $(0.17) per share. Despite the loss, profitability metrics and cash generation improved meaningfully.
Adjusted EBITDA nearly doubled to $4.1 million, driven by stronger performance in the Education Division, where revenue rose 16% to $17.5 million. Enterprise Division revenue declined to $41.6 million, as lower prior-year invoicing weighed on current subscription revenue, although Enterprise North America invoiced amounts grew 7% for the second quarter in a row.
Deferred revenue increased to $101.5 million, and free cash flow strengthened, with $13.2 million generated in the quarter and $9.5 million over the first half. The company repurchased approximately 947,000 shares for $17.0 million and ended the quarter with over $76 million of available liquidity while affirming full-year guidance for revenue of $265–$275 million and Adjusted EBITDA of $28–$33 million.
Franklin Covey Co ownership filing: an amendment to a Schedule 13G/A reports that The Vanguard Group holds 0 shares of Franklin Covey Co common stock, representing 0% of the class. The amendment explains an internal realignment effective January 12, 2026, causing certain Vanguard subsidiaries or divisions to report separately.
Franklin Covey Co. plans to review its second quarter 2026 financial results on a conference call scheduled for Wednesday, April 1, 2026, at 5:00 p.m. ET (3:00 p.m. MT). The results are expected to be released after the market closes that day.
Investors can join via a live webcast or by registering for phone access, including a “Call Me” option that connects directly to their phone. Registration is required for all participants. A replay of the webcast will be available on the company’s website for at least 30 days.
AllianceBernstein L.P. has filed an amended Schedule 13G reporting beneficial ownership of 1,143,853 shares of Franklin Covey Co common stock, representing 9.5% of the class as of 12/31/2025. These shares are held in discretionary investment advisory accounts for clients.
AllianceBernstein has sole voting power over 1,088,347 shares and sole dispositive power over 1,143,853 shares, with no shared voting or dispositive power. The filing states the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of Franklin Covey.
Franklin Covey director Robert A. Whitman reported a transfer of 4,834 common shares on January 29, 2026. The transaction, coded "G," was recorded at a price of $0 per share. After this change, he directly beneficially owns 707,977 common shares of Franklin Covey.
Franklin Covey director Nancy R. Phillips received 5,778 common shares of the company on January 23, 2026, at a price of $0 per share. This acquisition increased her directly held stake to 20,951 common shares following the transaction. The filing characterizes the transaction as an acquisition rather than a sale, and all reported shares are held directly in her name.
Franklin Covey director reports share acquisition. Director Efrain Rivera reported acquiring 5,778 Franklin Covey common shares on January 23, 2026 in a transaction coded as an acquisition at a price of $0 per share. Following this transaction, he beneficially owns 12,087 common shares, held in direct ownership form. The filing indicates this was a non-derivative transaction in the company’s common shares, with no derivative securities reported.
Franklin Covey director Derek C M Van Bever reported a stock grant. On 01/23/2026, he acquired 5,778 common shares of Franklin Covey at a price of $0 per share, indicating a share award rather than an open-market purchase. After this transaction, he beneficially owned a total of 24,011 common shares, held directly. This filing reflects an update to his ownership position as a director of the company.
Franklin Covey director Donald J. McNamara acquired 5,778 common shares on January 23, 2026 in a transaction recorded at $0 per share, indicating a share grant rather than an open-market purchase. Following this award, he directly owns 459,980 common shares of Franklin Covey. The filing reflects an increase in his equity stake and confirms that the ownership is held directly rather than through an intermediary entity.
Franklin Covey director Robert A. Whitman reported a stock award from the company. On January 23, 2026, he acquired 5,778 common shares of Franklin Covey at a price of $0 per share, indicating this was a grant rather than an open-market purchase. After this transaction, he beneficially owned 712,811 common shares, held directly.